Amdocs, Ltd.

Marn v. Amdocs Limited et al.

On March 31, 2021, pre-market, Jehoshaphat Research published a short-seller report addressing Amdocs, which alleged, inter alia, that Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; that there was a concerning pattern of reputable auditors resigning, only to be replaced by "scandal-plagued or tiny shops"; that Amdocs "window-dressed" its balance sheets to keep its large borrowing a secret, namely by paying down its debt just prior to the end of each quarter, therefore showing a debt-free balance sheet on that day, before re-borrowing the money shortly thereafter; and that all of the foregoing was corroborated by former employees and direct competitors of the Company, who noted that Amdocs was losing AT&T as a customer, as well as a former American Amdocs executive, who stated that the Company's "US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable." On this news, Amdocs' ordinary share price fell $9.19 per share, or 11.58%, to close at $70.15 per share on March 31, 2021.

Lead Plaintiff deadline
June 8, 2021
class period
December 13, 2016
March 30, 2021
Case Documents
No documents available. Contact us if you need a case document.